Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- PIIS1525730420301352
Final published version, 971 KB, PDF document
| Original language | English |
|---|---|
| Journal | Clinical Lung Cancer |
| Volume | 22 |
| Issue number | 4 |
| Pages (from-to) | e528-e532 |
| Number of pages | 5 |
| ISSN | 1525-7304 |
| DOIs | |
| Publication status | Published - 2021 |
Number of downloads are based on statistics from Google Scholar and www.ku.dk
No data available
ID: 247177786